Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.392EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.392EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.392ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.392ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.392EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.392EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.392ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.392ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.377EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.377ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.377ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.377EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.377EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.377ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.377ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.5.3 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.5.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.3 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.5.3 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.5.3 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.5.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.5.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.5.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BB.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
BB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BB.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
BB.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BB.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BB.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.86 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.86 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.86 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.86 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.86 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.86 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.86 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.86 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.595.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.595.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.595.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.595.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used